Inflammation is pointed out as both a potential consequence and a cause of neurodegenerative processes. Yet the role of inflammatory factors in the pathophysiology of Parkinson’s disease and atypical Parkinsonian disorders has not been explored yet. My study will allow for comparing the levels of inflammation parameters in the course of Parkinson’s disease and progressive supranuclear palsy, as well as identifying differences between those subtypes, writes Piotr Alster, PhD Hab., from the WUM Department of Neurology at the Faculty of Health Sciences.

